Company Filing History:
Years Active: 2013-2016
Title: The Innovative Contributions of Patrick Erbacher in RNA Interference
Introduction: Patrick Erbacher, an accomplished inventor based in Benfeld, France, has made significant strides in the field of molecular biology through his innovative work. With a total of four patents, his contributions are primarily focused on the development of oligonucleotides for RNA interference and their therapeutic applications.
Latest Patents: Among Patrick Erbacher's notable achievements are his latest patents concerning oligonucleotides for RNA interference. These inventions relate to compositions containing double-stranded oligonucleotides that possess identical or varying sequences and lengths. Specifically, these oligonucleotides include a sequence denoted as N...N...N, wherein N... represents half of a double-stranded 19-28 mer oligonucleotide that is complementary to a target nucleic acid sequence found in living cells. The additional N... signifies a 3-50 mer overhang sequence that facilitates the oligomerization of the double-stranded oligonucleotide. His innovative compositions include transfection methodologies utilizing these oligonucleotides for therapeutic applications, pointing towards potential advancements in gene therapy.
Career Highlights: Throughout his career, Patrick Erbacher has been affiliated with prominent companies such as Polyplus-Transfection, where he contributed to the advancement of transfection technologies. His work in this innovative environment has allowed him to pioneer techniques that can transform therapeutic approaches in molecular biology.
Collaborations: Collaboration has been a fundamental aspect of Patrick Erbacher's career. Notable coworkers include Anne-Laure Bolcato Bellemin and Jean-Paul Behr, with whom he has shared insights and knowledge to push the boundaries of research and development in his field.
Conclusion: Patrick Erbacher's contributions to the field of RNA interference and biological applications through his patented inventions underscore his role as a pioneering inventor. His commitment to innovation and collaboration with fellow researchers emphasizes the critical impact of oligonucleotide research in modern science and medicine. As he continues to explore new avenues of research, his work promises to leave a lasting legacy in the world of biotechnology.